The present application describes pyrazolobenzamides and derivatives
thereof of Formula I: P.sub.4-P-M-M.sub.4 I or pharmaceutically
acceptable salt forms thereof. Compounds of the present invention are
useful as inhibitors of trypsin-like serine proteases, specifically
factor Xa.